Indonesian Political, Business & Finance News

Amid 5.75% BI Rate, IPO Companies Prioritise Debt Repayment

| Source: CNBC Indonesia Translated from Indonesian | Finance
Amid 5.75% BI Rate, IPO Companies Prioritise Debt Repayment
Image: CNBC Indonesia

Several issuers are preparing for their Initial Public Offerings (IPO) on the Indonesia Stock Exchange (IDX) towards the end of the first semester of this year. According to IDX disclosure information, there are six prospective issuers scheduled to list on the capital market in July 2026.

These six prospective issuers include PT Niramas Utama Tbk. (JELI), PT Prodia Diagnostic Line Tbk (PRDL), PT Esa Medika Mandiri Tbk (EMMI), PT Nitrasanata Dharma Tbk. (JECX), PT Bach Multi Global Tbk (BACH), and the company owned by Raffi Ahmad, PT RANS Entertainment Indonesia Tbk (RANS).

This current IPO phenomenon is quite striking. Amid the trend of benchmark interest rate increases by Bank Indonesia (BI), most prospective issuers are instead prioritising the use of IPO proceeds to settle bank debts.

PT Niramas Utama Tbk. (Jolli) will release 350,000,000 shares, or 25.93% of its placed and paid-up capital, with a nominal value of Rp100 per share. The shares offered to the public are priced in the range of Rp900 to Rp1,120 per share. The listing date on the Indonesia Stock Exchange is set for 7 July 2026. One of the uses of the IPO proceeds is that approximately 10.63% will be used for the partial repayment of short-term debt principal.

Meanwhile, Raffi Ahmad’s company, PT RANS Entertainment Indonesia Tbk (RANS), is offering up to 2.52 billion new shares, equivalent to 20.02% of its fully placed and paid-up capital after the IPO. In this corporate action, RANS has set an offering price range of Rp135 to Rp170 per share. The estimated listing date on the Indonesia Stock Exchange (IDX) is 10 July 2026. One use of the IPO funds, approximately 6.98%, will be used for the accelerated repayment of the entire principal debt to PT Bank Negara Indonesia (Persero) Tbk.

Furthermore, PT Bach Multi Global Tbk (BACH) is offering 615 million new shares, or 15.06% of its fully placed and paid-up capital after the IPO. The offering price is in the range of Rp400-Rp500 per share. The listing on the Indonesia Stock Exchange is scheduled for 7 July 2026. Part of the IPO funds, approximately Rp91.02 billion, will be used to pay part of a loan to PT Bank Permata Tbk.

Additionally, PT Nitrasanata Dharma Tbk. (JECX) will conduct an Initial Public Offering of up to 487,983,500 ordinary shares, consisting of 325,322,300 shares from placed and paid-up capital and 162,661,200 shares owned by Dr. Dr. Waldensius Girsang, representing up to 15% of the placed and paid-up capital with a value of Rp16 per share. The price offered to the public is in the range of Rp1,200 to Rp1,400 per share. The listing date on the Indonesia Stock Exchange is 7 July 2026. The company intends to use Rp40,000,000,000 of the IPO proceeds for early repayment to PT Bank Central Asia Tbk, and Rp100,000,000,000 for early repayment to PT Bank HSBC Indonesia (HSBC) regarding portions of the company’s loan principals.

There is also PT Esa Medika Mandiri Tbk (EMMI), which is offering up to 522.86 million new shares, representing a maximum of 30% of the company’s fully placed and paid-up capital after the IPO. In this corporate action, the company is offering shares at a price range of Rp446 to Rp515 per share. The listing on the Indonesia Stock Exchange (IDX) is scheduled for 8 July 2026. Approximately Rp50 billion will be allocated for the partial repayment of the company’s loan principal.

Finally, PT Prodia Diagnostic Line Tbk (PRDL) is offering up to 522.9 million new shares, or 30% of its fully placed and paid to-up capital after the IPO. PRDL has set an offering price range of Rp100-Rp120 per share. The listing on the IDX is scheduled for 9 July 2026. The use of IPO funds for these issuers is more oriented towards improving balance sheets rather than aggressive expansion. From the total funds raised, approximately Rp35.67 billion will be used to settle loan principals to PT Bank Central Asia Tbk (BCA) and PT Bank Pan Indonesia Tbk (Panin Bank).

This means that more than half of the IPO proceeds are potentially destined for debt repayment, rather than building new factories, significantly increasing production capacity, or undertaking large-scale market expansion. In a high-interest-rate environment, these prospective issuers tend to prioritise strengthening capital structures and reducing interest burdens instead of pursuing risky expansions.

Furthermore, amidst the trend of Bank Indonesia’s benchmark interest rate increases, which are expected to keep borrowing costs at high levels, companies tend to choose to improve their balance sheets to be more resilient to interest rate pressures while simultaneously increasing investor confidence in their post-IPO financial condition.

This phenomenon indicates that fund-raising strategies in the capital market are beginning to shift. Amid more expensive financing costs, companies are not only seeking additional capital for expansion but are also utilising IPOs as a momentum to improve capital structure and reduce debt ratios.

For information, Bank Indonesia, in its Board of Governors Meeting on 17-18 June 2026, decided to raise the BI Rate by 25 basis points to 5.75%. In less than one month, the central bank has raised the benchmark interest rate three times, with a total increase of 100 basis points.

More from 26 June 2026 →

Cite this article
Source: jawawa.id (https://jawawa.id/newsitem/amid-5-75-bi-rate-ipo-companies-prioritise-debt-repayment-1782445884)
Originally published by CNBC Indonesia (https://www.cnbcindonesia.com/market/20260626091730-17-745881/di-tengah-bi-rate-575-emiten-ipo-pilih-bayar-utang), translated from Indonesian
Print